Sensenig Bethany
SEC Form 4 insider trading activity
Sensenig Bethany has filed 2 SEC Form 4 filings (4 transaction rows) across 2 companies, including ACOG, SUPN, with disclosures dating back to 2026. 2 of those filings fall inside the rolling window. Most recent filing: Apr 17, 2026.
On the most recent filing, Sensenig Bethany is listed as Director at SUPERNUS PHARMACEUTICALS, INC. Inside the rolling window, Sensenig Bethany reported no open-market purchases and 1 open-market sale totaling $228K in SUPN.
Companies traded
Other insiders at ACOG
Insider Buying
$0
reported purchases (SEC code P)
Insider Selling
$228K
reported sales (SEC code S)
Companies
2
in the rolling window
Frequently asked questions
How many SEC Form 4 filings has Sensenig Bethany made?
Sensenig Bethany has filed 2 SEC Form 4 filings (4 transaction rows) across 2 companies, including ACOG, SUPN since 2026.
Which companies does Sensenig Bethany trade?
Sensenig Bethany has filed SEC Form 4 disclosures for 2 companies, including ACOG, SUPN.
When was Sensenig Bethany's most recent SEC Form 4 filing?
Sensenig Bethany's most recent SEC Form 4 filing on Tracefour is dated Apr 17, 2026.
What is Sensenig Bethany's total buy and sell value in the current window?
Inside the rolling retention window, Sensenig Bethany bought $0 and sold $228K based on SEC Form 4 filings.
What was Sensenig Bethany's largest disclosed transaction?
The largest disclosed transaction in the current window is a sale of 4,475 SUPN shares on 2026-02-19, worth $228K, per SEC Form 4 filings.